Cancer survival in Africa, Asia, the Caribbean and Central America (SurvCan)

Comparative statistics by cancer registry

(Chennai, India, 1990-1999 cases followed-up to 2001)

Click on cancer site (ICD-10 code) for comparison

Site	ICD-10	No. of cases included	Complete FU		Incomplete FU: loss to FU						% with Complete FU at 5 years	Median FU (in months)
			Alive/dead	At end of FU	No.	%	% lost to FU: years from diagnosis
			No.	%	No.	%	<1	1-3	3-5	>5
C00	Lip	86	56	65.1	30	34.9	7.0	2.3	0.0	25.6	90.7	27.3
C01-02	Tongue	988	747	75.6	241	24.4	13.1	2.6	1.2	7.5	83.1	9.8
C03-06	Oral cavity	1662	1221	73.5	441	26.5	10.3	2.2	1.8	12.2	85.6	12.9
C09	Tonsil	250	230	92.0	20	8.0	4.8	0.8	0.0	2.4	94.4	10.3
C10	Other oropharynx	158	151	95.6	7	4.4	0.6	0.6	0.0	3.2	98.7	11.0
C12-13	Hypopharynx	1017	892	87.7	125	12.3	9.0	0.7	0.3	2.3	90.0	8.7
C15	Oesophagus	2016	1818	90.2	198	9.8	6.7	0.9	0.4	1.8	92.0	6.9
C16	Stomach	2681	2397	89.4	284	10.6	7.3	0.9	0.9	1.5	90.9	6.1
C25	Pancreas	328	314	95.7	14	4.3	3.1	0.3	0.3	0.6	96.3	4.3
C32	Larynx	722	598	82.8	124	17.2	6.7	0.8	0.3	9.4	92.2	17.4
C33-34	Lung	1806	1619	89.6	187	10.4	8.0	0.7	0.3	1.4	91.1	5.8
C50	Breast	3067	2351	76.7	716	23.3	12.4	2.9	2.0	6.0	82.6	26.9
C53	Cervix	4438	2752	62.0	1686	38.0	11.0	3.7	2.5	20.8	82.8	27.5
C56	Ovary	808	625	77.4	183	22.6	14.7	4.6	1.4	1.9	79.2	11.4
C67	Urinary bladder	442	367	83.0	75	17.0	10.9	1.6	0.2	4.3	87.3	11.7
C81	Hodgkin lymphoma	298	245	82.2	53	17.8	6.4	1.7	1.0	8.7	90.9	21.0
C82-85+C96	Non-Hodgkin lymphoma	868	732	84.3	136	15.7	10.9	1.3	0.6	2.9	87.2	9.4
C91	Lymphoid leukaemia	433	372	85.9	61	14.1	2.8	3.2	3.5	4.6	90.5	8.5
C92-94	Myeloid leukaemia	465	400	86.0	65	14.0	8.6	1.3	0.4	3.7	89.7	4.5
C95	Leukaemia unspecified	85	74	87.1	11	12.9	10.5	0.0	0.0	2.4	89.4	1.5

Other tables available for this registry:

- Table1:	Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Chennai, India, 1990-1999 cases followed-up to 2001)
- Table2a:	Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site (Chennai, India, 1990-1999 cases followed-up to 2001)
- Table3:	Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Chennai, India, 1990-1999 cases followed-up to 2001)
- Table4:	Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Chennai, India, 1990-1999 cases followed-up to 2001)
- Table5b:	Proportion (%) of cases and 5-year absolute survival by extent of disease and site (Chennai, India, 1990-1999)
- Table6:	Comparison of 5-year absolute and relative survival of cases diagnosed between 1984-1989 and 1990-1999 (Chennai, India)

Registry chapter: